Rise Therapeutics

Rise Therapeutics

Edit info

  • Founded: 2017
  • Location: Rockville, MD
  • Employee range: 11 - 50
  • Clinical stage: Clin1
  • Therapy area: Ulcerative colitis
  • Drug types: IMM, GEN, GI, ONC
  • Lead product: R-3750
  • Funding: <10M


risetherapeutics.com

linkedin.com

job board


Drug notes:

R-2487 Clin0 Sjogren's syndrome, autoimmune diseases; R-5780 Clin0 oncology; undisclosed programs RD undisclosed

About:

Rise Therapeutics is developing oral immunotherapies to treat a wide variety of human diseases. By merging their understanding of immune therapy with discoveries of how the microbiome functions, Rise has created their Tripartite X (TPX) drug delivery platform. TPX is a novel synthetic biology approach that allows oral delivery of protein-based drugs by encapsulating them inside probiotics. Rise’s approach combines low-cost product manufacturing and convenient oral capsule dosing overcoming traditional approaches that require injection or infusion. Rise has established a diverse pipeline at clinical stages for various immune diseases.

Jobs:

Post a job


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com